EcoDrugPlus

Ensembl ID : ENSVVUG00000029440
Gene Symbol: -
Cross references: -
237 Possible Orthologues:

Ensembl ID : ENSVVUG00000004721
Gene Symbol: -
Cross references: -
250 Possible Orthologues:

Ensembl ID : ENSVVUG00000003544
Gene Symbol: -
Cross references: -
163 Possible Orthologues:

Ensembl ID : ENSVVUG00000010046
Gene Symbol: -
Cross references: -
88 Possible Orthologues:

Ensembl ID : ENSVVUG00000001480
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSVVUG00000025342
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSVVUG00000025570
Gene Symbol: -
Cross references: -
101 Possible Orthologues:

Ensembl ID : ENSVVUG00000001431
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSVVUG00000028538
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSVVUG00000010815
Gene Symbol: -
Cross references: -
127 Possible Orthologues:

Ensembl ID : ENSVVUG00000024840
Gene Symbol: -
Cross references: -
25 Possible Orthologues:

Ensembl ID : ENSVVUG00000024535
Gene Symbol: -
Cross references: -
224 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).